Format

Send to

Choose Destination
Ophthalmic Surg Lasers Imaging. 2010 Mar-Apr;41(2):228-35. doi: 10.3928/15428877-20100303-12.

Does phacoemulsification affect the long-term success of non-penetrating deep sclerectomy?

Author information

1
Paletta Guedes Ophthalmic Center, Federal University of Juiz de Fora, Brazil.

Abstract

BACKGROUND AND OBJECTIVE:

Phaco non-penetrating deep sclerectomy (PhacoNPDS) is an option to simultaneously treat cataract and glaucoma. The authors assessed tensional success of PhacoNPDS and NPDS up to 3 years of follow-up.

PATIENTS AND METHODS:

A longitudinal consecutive retrospective study was conducted comparing 376 eyes undergoing NPDS (group 1) and 87 eyes undergoing PhacoNPDS (group 2). Success was defined as complete 1 (intraocular pressure [IOP] < 21 mm Hg without medication); complete 2 (at least a 20% reduction of preoperative IOP without medication), and qualified (IOP < 21 mm Hg with or without medication).

RESULTS:

Preoperative IOP and number of medications were 23.7 and 2.7 in group 1 and 23.1 and 2.6 in group 2, respectively. Postoperative IOP (3 years) was 13.1 mm Hg in group 1 and 13.4 mm Hg in group 2 (P = .000). Complete 1, complete 2, and qualified success in 3 years were 57.5%, 53.7%, and 94.5% in group 1 and 56.1%, 56.1%, and 100% in group 2, respectively (P = .861, .772, and .159). Final number of medications was 0.5 in group 1 and 0.3 in group 2.

CONCLUSION:

PhacoNPDS seems to achieve similar tensional results as NPDS alone up to 3 years of follow-up.

PMID:
20307042
DOI:
10.3928/15428877-20100303-12
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center